Point72 Asset Management
CHRS icon

Point72 Asset Management’s Coherus Oncology CHRS Stock Holding History

Point72 Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,283,292
Closed -$7.29M – 2096
2024
Q4 		$7.29M Buy
+5,283,292
New +$5.93M 0.02% 821
2023
Q4 		– Sell
-7,491
Closed -$28K – 2241
2023
Q3 		$28K Sell
7,491
-952,530
-99% -$4.4M ﹤0.01% 2244
2023
Q2 		$4.1M Buy
+960,021
New +$5.66M 0.01% 873
2022
Q3 		– Sell
-135,800
Closed -$983K – 1433
2022
Q2 		$983K Sell
135,800
-572,200
-81% -$4.98M ﹤0.01% 1080
2022
Q1 		$9.14M Buy
708,000
+377,700
+114% +$4.8M 0.04% 539
2021
Q4 		$5.27M Buy
+330,300
New +$5.78M 0.02% 653
2019
Q2 		– Sell
-917,896
Closed -$12.5M – 1357
2019
Q1 		$12.5M Buy
+917,896
New +$12.2M 0.06% 351
2018
Q4 		– Sell
-150,000
Closed -$2.48M – 986
2018
Q3 		$2.48M Sell
150,000
-162,800
-52% -$2.89M 0.01% 731
2018
Q2 		$4.38M Buy
+312,800
New +$4.48M 0.02% 636
2017
Q1 		– Sell
-601,034
Closed -$16.9M – 822
2016
Q4 		$16.9M Buy
+601,034
New +$16.8M 0.12% 212
2016
Q3 		– Sell
-37,500
Closed -$633K – 723
2016
Q2 		$633K Sell
37,500
-93,700
-71% -$1.76M ﹤0.01% 648
2016
Q1 		$2.79M Buy
+131,200
New +$2.15M 0.02% 526

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Point72 Asset Management's CHRS Position: Q1 2025 in Review

Point72 Asset Management sold out of Coherus Oncology (CHRS) in Q1 2025, closing a stake of 5,283,292 shares — an estimated $7.29M sold.

Point72 Asset Management first reported a position in CHRS in Q1 2016 and held it in 12 quarters. The position peaked at $16.9M in Q4 2016. 117 funds tracked by Wall St. Rank hold CHRS as of Q1 2025.

  • Point72 Asset Management reported no remaining Coherus Oncology position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 5,283,292 Coherus Oncology shares in Q1 2025, an estimated $7.29M.
  • Point72 Asset Management first reported a position in Coherus Oncology in Q1 2016 and held it in 12 quarters.
  • Point72 Asset Management's Coherus Oncology position peaked at $16.9M in Q4 2016.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.